1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow RGB 286638: new trials by email Literature Review of RGB 286638 trials Research Report on RGB 286638
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies RGB-286638 - Hematological Malignancies | Phase 1 | Withdrawn | Agennix | 2011-11-01 | 2012-08-02 |
Agennix (1)